Literature DB >> 25976550

European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens.

Adolf E Schindler1, Howard Carp, René Druckmann, Andrea R Genazzani, Johannes Huber, Jorge Pasqualini, Karl W Schweppe, Julia Szekeres-Bartho.   

Abstract

This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

Keywords:  Miscarriage; prevention; progestogens

Mesh:

Substances:

Year:  2015        PMID: 25976550     DOI: 10.3109/09513590.2015.1017459

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

1.  Effect of dydrogesterone and progesterone on threatened miscarriage due to corpus luteum insufficiency.

Authors:  Caiyu Lou; Caiwen Wang; Qiang Zhao; Fenyuan Jin
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 2.  The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage.

Authors:  Hisham Arab; Ahmed Jaber Alharbi; Ayman Oraif; Emad Sagr; Hana Al Madani; Hassan Abduljabbar; Osama Sadeak Bajouh; Yaser Faden; Yasser Sabr
Journal:  Int J Womens Health       Date:  2019-11-07

3.  Baseline Levels of Serum Progesterone and the First Trimester Pregnancy Outcome in Women with Threatened Abortion: A Retrospective Cohort Study.

Authors:  Yongshi Deng; Chi Chen; Siyun Chen; Guanyan Mai; Xiuping Liao; He Tian; Wenli Liu; Shuling Ji; Ying Liu; Jie Gao; Songping Luo
Journal:  Biomed Res Int       Date:  2020-03-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.